Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year
ALTAltimmune(ALT) The Motley Fool·2024-08-09 20:46

Altimmune is a little-known pharmaceutical company looking to disrupt the weight loss space.One of the biggest movements in the pharmaceutical industry right now is developing medications for weight loss. Glucagon-like peptide-1 (GLP-1) agonists such as Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, and Zepbound are transforming how diabetes and obesity are treated.What's amazing is that all of the medications listed above are manufactured by just two companies: Novo Nordisk (NVO 7.50%) and Eli Lilly (LLY 9. ...